LY-307,452
LY-307,452
LY-307,452 (pronunciation: L-Y-Three-Zero-Seven-Four-Five-Two) is a pharmacological compound that is often used in scientific research.
Etymology
The name "LY-307,452" is derived from the naming convention used by Eli Lilly and Company, the pharmaceutical company that first synthesized the compound. The "LY" stands for "Lilly", and the numbers are a unique identifier for the compound.
Description
LY-307,452 is a non-selective antagonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It is often used in scientific research to study the effects of these receptors on various physiological and psychological processes.
Related Terms
- Serotonin: A neurotransmitter that is believed to play a major role in mood and anxiety disorders.
- Antagonist: A type of drug that blocks the action of a specific neurotransmitter or hormone.
- 5-HT2A receptor: One of the several different subtypes of the 5-HT2 receptor that resides primarily in the cerebral cortex of the brain.
- 5-HT2B receptor: A subtype of the 5-HT2 receptor that is primarily found in the stomach fundus, uterus, vascular smooth muscle, and platelets.
- 5-HT2C receptor: A subtype of the 5-HT2 receptor that is primarily found in the choroid plexus, cortex, and limbic regions of the brain.
External links
- Medical encyclopedia article on LY-307,452
- Wikipedia's article - LY-307,452
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski